Both are pharmacopoeial reference standards, but the numbering, the intended use and the documentation differ. A practical comparison for analytical labs.
Both EP and USP publish impurity standards for the same drug substances, and the two are often treated as interchangeable. They are not identical, and the difference matters when a method is transferred between markets.
EP uses letters (Impurity A, B, C) assigned in the monograph; USP uses letters as well but the assignment can differ for the same substance. A method written against "Impurity C" in one pharmacopoeia may point at a different structure in the other. Always confirm by structure and CAS, not by letter.
EP reference standards are qualified for the tests in the Ph. Eur. monograph; USP Reference Padrãos are qualified for the tests in the USP–NF. Using one to replace the other is a deviation that has to be justified in the filing.
Both come with a lot certificate, but the content differs: EP certificates are terse, USP certificates carry the assigned chromatographic purity and the intended use statement. For an audit trail, pair the pharmacopoeial certificate with an identity confirmation (MS, 1H NMR) from the supplier.
Buy the pharmacopoeial standard for the market you are filing in, and buy a characterised non-pharmacopoeial standard for method development, system suitability and impurity identification. That is how our catalogue is organised: pharmacopoeial impurities are listed separately from the rest.